Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 2—February 2008

Letter

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis

Asmaa Tazi*†‡, Thomas Gueudet§, Emanuelle Varon*, Liliane Gilly‡, Patrick Trieu-Cuot*¶, and Claire Poyart*†‡¶Comments to Author 
Author affiliations: *Assistance Publique-Hôpitaux de Paris, Paris, France; †Institut National de la Santé de la Recherche Médicale, Paris, France; ‡Université Paris Descartes, Paris, France; §Laboratoire Schuh-Biosphere, Strasbourg, France; ¶Institut Pasteur, Paris, France;

Main Article

Table

MICs of fluoroquinolones for strains of group B streptococci (GBS), France

Strain
MIC (mg/L)*
Pef
Nor
Cip
Spa
Lev
Mox
GBS CNR07017 >64 >64 4 1 4 1
GBS NEM316 16 8 2 0.5 1 0.25

*Pef, pefloxacin; Nor, norfloxacin; Cip, ciprofloxacin; Spa, sparfloxacin; Lev, levofloxacin; Mox, moxifloxacin.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO